First Time Loading...

Avanos Medical Inc
NYSE:AVNS

Watchlist Manager
Avanos Medical Inc Logo
Avanos Medical Inc
NYSE:AVNS
Watchlist
Price: 19.91 USD 0.05% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Avanos Medical, Inc. operates as a medical technology company. [ Read More ]

The intrinsic value of one AVNS stock under the Base Case scenario is 35.44 USD. Compared to the current market price of 19.91 USD, Avanos Medical Inc is Undervalued by 44%.

Key Points:
AVNS Intrinsic Value
Base Case
35.44 USD
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Avanos Medical Inc

Backtest AVNS Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AVNS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Avanos Medical Inc's business.

What risks and challenges
does Avanos Medical Inc face in the near future?

Summarize the latest earnings report
of Avanos Medical Inc.

Provide P/E
for Avanos Medical Inc and its competitors.

Financials

Balance Sheet Decomposition
Avanos Medical Inc

Current Assets 487m
Cash & Short-Term Investments 87.7m
Receivables 142.8m
Other Current Assets 256.5m
Non-Current Assets 1.2B
PP&E 144m
Intangibles 1B
Other Non-Current Assets 25.8m
Current Liabilities 234.6m
Accounts Payable 56.3m
Accrued Liabilities 106m
Other Current Liabilities 72.3m
Non-Current Liabilities 221.5m
Long-Term Debt 159.4m
Other Non-Current Liabilities 62.1m
Efficiency

Earnings Waterfall
Avanos Medical Inc

Revenue
673.3m USD
Cost of Revenue
-293.6m USD
Gross Profit
379.7m USD
Operating Expenses
-375.5m USD
Operating Income
4.2m USD
Other Expenses
-66m USD
Net Income
-61.8m USD

Free Cash Flow Analysis
Avanos Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

AVNS Profitability Score
Profitability Due Diligence

Avanos Medical Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
ROIC is Increasing
43/100
Profitability
Score

Avanos Medical Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

AVNS Solvency Score
Solvency Due Diligence

Avanos Medical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
50/100
Solvency
Score

Avanos Medical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AVNS Price Targets Summary
Avanos Medical Inc

Wall Street analysts forecast AVNS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVNS is 23.97 USD with a low forecast of 20.2 USD and a high forecast of 28.35 USD.

Lowest
Price Target
20.2 USD
1% Upside
Average
Price Target
23.97 USD
20% Upside
Highest
Price Target
28.35 USD
42% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

AVNS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

AVNS Price
Avanos Medical Inc

1M 1M
+7%
6M 6M
-2%
1Y 1Y
-30%
3Y 3Y
-55%
5Y 5Y
-53%
10Y 10Y
-51%
Annual Price Range
19.91
52w Low
17.64
52w High
30.98
Price Metrics
Average Annual Return -8.2%
Standard Deviation of Annual Returns 26.93%
Max Drawdown -67%
Shares Statistics
Market Capitalization 919.3m USD
Shares Outstanding 46 203 000
Percentage of Shares Shorted 3.87%

AVNS Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Avanos Medical Inc Logo
Avanos Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

919.3m USD

Dividend Yield

0%

Description

Avanos Medical, Inc. operates as a medical technology company. The company is headquartered in Alpharetta, Georgia and currently employs 4,555 full-time employees. The company went IPO on 2014-10-21. The firm develops, manufactures and markets solutions in approximately 90 countries. The company provides a portfolio of product offerings focused on chronic care and pain management to improve patient outcomes. Chronic care is a portfolio of products, which include digestive health products, such as its Mic-Key enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as its closed airway suction systems and other airway management devices under the Ballard, Microcuff and Endoclear brands. Pain management is a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and Interventional pain solutions, which provides pain relieving therapies, such as its Coolief pain therapy.

Contact

GEORGIA
Alpharetta
5405 Windward Parkway, Suite 100 South
+18444282667.0
https://avanos.com/

IPO

2014-10-21

Employees

4 555

Officers

CEO & Director
Mr. Joseph F. Woody
Senior VP, CFO & Chief Transformation Officer
Mr. Michael C. Greiner
Senior VP, General Counsel & Corporate Secretary
Ms. Mojirade James
Senior VP, GM of Chronic Care & Chief Commercial Officer
Mr. Kerr W. Holbrook
Principal Accounting Officer & Controller
Mr. John Joseph Hurley
VP of FP&A and Investor Relations and Treasurer
Mr. David Crawford
Show More
Senior VP and Chief Ethics & Compliance Officer
Ms. Michelle Scharfenberg
Vice President of Strategy & Corporate Development
Mr. Scott Galovan
Vice President of Human Resources
John W. Cato
Senior Vice President of Global R&D, Clinical and Medical Affairs
Mr. Lee Burnes
Show Less

See Also

Discover More
What is the Intrinsic Value of one AVNS stock?

The intrinsic value of one AVNS stock under the Base Case scenario is 35.44 USD.

Is AVNS stock undervalued or overvalued?

Compared to the current market price of 19.91 USD, Avanos Medical Inc is Undervalued by 44%.